Early Clinical Outcomes After Mitral Valve Repair Versus Replacement Combined With Coronary Artery Bypass Grafting in Patients With Ischemic Mitral Regurgitation

Authors

  • Mohammad Saeed Gassar, Ahmed Hassan Zaid, Ramadan Ibrahim Mohamed Ibrahim Auf, Eslam Elshafey, Ahmed Mohamed Elsonbaty, Mohamed Moaz Hasanain Author

DOI:

https://doi.org/10.64149/

Keywords:

Ischemic Mitral Regurgitation; Mitral Valve Repair; Mitral Valve Replacement; Coronary Artery Bypass Grafting; Cardiopulmonary Bypass.

Abstract

Background: Ischemic mitral regurgitation (IMR) is linked to poor left ventricular remodeling and worse long-term outcomes, and it commonly exacerbates coronary artery disease.

Aim: To compare the early postoperative outcomes of mitral valve repair versus replacement combined with coronary artery bypass grafting (CABG) in patients with ischemic mitral regurgitation.

Patients and Methods: This prospective comparative study included 80 patients with ischemic mitral regurgitation undergoing CABG at Al-Ahrar Teaching Hospital and National Heart Institute. Patients were equally assigned to mitral valve repair with ring annuloplasty (Group I, n = 40) or mitral valve replacement with a mechanical or bioprosthetic valve (Group II, n = 40), both combined with CABG. Baseline characteristics, preoperative findings, intraoperative variables, postoperative course and complications, and discharge echocardiographic outcomes were compared between groups.

Results: The replacement group had significantly longer aortic cross-clamp time (86.1 ± 18.7 vs. 69.2 ± 15.4 min, P = 0.001) and a longer ICU stay [median 3 days (range 2–7) vs. 3 days (range 1–5), P = 0.046], with a trend toward longer cardiopulmonary bypass time (P = 0.06). Other postoperative outcomes, including ventilation time, hospital stay, inotrope or IABP use, complications, and 30-day mortality (2.5% in each group), were comparable. Discharge LVEF was also similar (P = 0.744), whereas the median residual MR grade was significantly lower after replacement.

Conclusion: Mitral valve repair and replacement showed similar 30-day mortality and surgical morbidity in patients with ischemic mitral regurgitation undergoing concomitant CABG. Replacement was associated with longer ICU and cross-clamp times but provided more reliable early correction of MR, whereas repair had shorter operative courses but a higher rate of residual moderate-to-severe MR. The choice should therefore be individualized based on valve morphology, subvalvular pathology, and operative risk.

Downloads

Published

2024-07-15

How to Cite

Early Clinical Outcomes After Mitral Valve Repair Versus Replacement Combined With Coronary Artery Bypass Grafting in Patients With Ischemic Mitral Regurgitation. (2024). Vascular and Endovascular Review, 7(2), 577-583. https://doi.org/10.64149/